UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Horizon Investment Services LLC

Horizon Investment Services LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,236 shares of the healthcare conglomerate’s stock after selling 872 shares during the quarter. Horizon Investment Services LLC’s holdings in UnitedHealth Group were worth $2,158,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in the stock. CapWealth Advisors LLC grew its position in shares of UnitedHealth Group by 4.9% during the second quarter. CapWealth Advisors LLC now owns 534 shares of the healthcare conglomerate’s stock worth $272,000 after buying an additional 25 shares in the last quarter. Waverton Investment Management Ltd lifted its stake in UnitedHealth Group by 10.5% during the second quarter. Waverton Investment Management Ltd now owns 397,201 shares of the healthcare conglomerate’s stock worth $202,253,000 after purchasing an additional 37,741 shares during the last quarter. First Business Financial Services Inc. lifted its stake in UnitedHealth Group by 2.0% during the second quarter. First Business Financial Services Inc. now owns 4,243 shares of the healthcare conglomerate’s stock worth $2,161,000 after purchasing an additional 85 shares during the last quarter. National Bank of Canada FI lifted its stake in UnitedHealth Group by 17.5% during the second quarter. National Bank of Canada FI now owns 1,111,876 shares of the healthcare conglomerate’s stock worth $549,917,000 after purchasing an additional 165,410 shares during the last quarter. Finally, SouthState Corp lifted its stake in UnitedHealth Group by 11.4% during the second quarter. SouthState Corp now owns 8,553 shares of the healthcare conglomerate’s stock worth $4,356,000 after purchasing an additional 874 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, August 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Monday, August 19th. HSBC raised their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Royal Bank of Canada raised their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Finally, Wells Fargo & Company lifted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Trading Down 1.4 %

Shares of NYSE UNH opened at $595.50 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The firm has a market capitalization of $549.90 billion, a PE ratio of 36.40, a PEG ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The business has a 50-day moving average price of $557.22 and a two-hundred day moving average price of $514.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the company posted $6.14 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.67 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.